Primary Category:
Cancer Care Delivery, Radiation Oncology
Disease Category:
Endometrial, Gynecologic
Status:
New, Open
A Phase III Randomized Trial of Radiation +/- MK-3475 (Pembrolizumab) for Newly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (dMMR) Endometrioid Endometrial Cancer
Eligible for screening study DCP 001
NCT#04214067
